Navigation Links
Intarcia Therapeutics Appoints Gino Santini To Its Board Of Directors
Date:7/26/2013

f the company's Executive Committee, Mr. Santini led corporate strategy and long-range planning, M&A, new product licensing, innovative financing of internal development projects, and the expansion of Lilly Ventures in the U.S. and China. In addition to Intarcia, Mr. Santini serves on the Boards of Directors of several other biopharmaceutical companies and an Italian financial holding company. Fluent in four languages, Mr. Santini holds an undergraduate degree in mechanical engineering from the University of Bologna, and an MBA from the Simon School of Business, University of Rochester.

Mr. Santini explained that his enthusiasm for joining the Intarcia Board is prompted most by the Company's potential opportunity to make a real difference in the lives of patients with type 2 diabetes:  "This is truly an exciting time in the evolution of Intarcia, and quite possibly in the future management of type 2 diabetes. I believe Intarcia has thoughtfully put together the handful of critical ingredients for major success: a differentiated and potentially game-changing lead product candidate, world-class scientific, manufacturing and business competencies, a strong Board and top-tier investors, and a proven team full of passion to outperform the marketplace and help patients. I look forward to working with the Board and senior leadership to help guide the company to the full measure of success possible."

About ITCA 650
ITCA 650 (a once- or twice-yearly continuous subcutaneous delivery of exenatide) is being developed for the treatment of type 2 diabetes. The investigational therapy employs Intarcia's proprietary technology platform involving a matchstick-size, miniature osmotic pump (minipump) that is inserted subcutaneously to provide continuous and consistent drug therapy, and the company's proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for exte
'/>"/>

SOURCE Intarcia Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Intarcia Appoints Owen Hughes Chief Business Officer and Head of Corporate Development
2. Intarcia Enrolls First Patients in "FREEDOM" Global Phase 3 Program for ITCA 650 in Type 2 Diabetes
3. Intarcia Supports American Diabetes Association Call For Independent Review Of Incretin-Based Therapies
4. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
5. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
6. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
7. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
8. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
9. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
10. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
11. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... 15, 2014  Over 200 patients, families, physicians ... to learn, interact and participate in the drive ... Lupus Trials Fair launched by the Lupus ... Lupus Foundation .  Attendees interacted directly with researchers ... experiences, ideas and needs and learning about more ...
(Date:9/15/2014)... 2014 Biomerics LLC, a leading provider ... announced its merger with Access Point Technologies and ... division was formed to provide next generation catheter ... structure heart, interventional radiology, interventional cardiology, and neurovascular ... will be led by Steve Berhow , ...
(Date:9/15/2014)... 2014 Chek Diagnostics, the U.S.-based manufacturer of ... point-of-care diagnostic products, has again been named to the ... companies in America. The Inc. 5000 ranking ... Chek Diagnostics earned its place on the list by ... 2013. For Chek Diagnostics, who appears on ...
Breaking Medicine Technology:Lupus Research Institute Launches NYC's First Lupus Trials Fair 2Lupus Research Institute Launches NYC's First Lupus Trials Fair 3Biomerics and Access Point Technologies OEM Announce Merger and Creation of Biomerics Advanced Catheter Division 2Chek Diagnostics Named to Inc. Magazine's 5000 Fastest Growing Private Companies List for the Fourth Time 2Chek Diagnostics Named to Inc. Magazine's 5000 Fastest Growing Private Companies List for the Fourth Time 3
(Date:9/15/2014)... 2014 The new North Valley Surgery ... near Raintree Dr. and Loop 101, after a ribbon ... dignitaries from the healthcare community on Friday, September 12, ... rooms, four gastro-intestinal procedure rooms, and a pain management ... largest surgery center in the state of Arizona. ...
(Date:9/15/2014)... York, New York (PRWEB) September 15, 2014 ... C.R. Bard, Inc. continue to move forward in the ... Southern District of West Virginia, Bernstein Liebhard LLP reports. ... issued a Final Order on September 10th that provides ... The Order notes that none of the affected plaintiffs ...
(Date:9/15/2014)... Mo. According to recent studies, approximately one out of ... of the gene responsible for spinal muscular atrophy (SMA), a ... researchers at the University of Missouri have made a recent ... be highly effective in animal models of the disease. In ... in SMA. , "The strategy our lab is using to ...
(Date:9/15/2014)... Alto, CA (PRWEB) September 15, 2014 ... anniversary since its founding in 2007. To mark the ... local community for supporting the village and helping it ... provides a safe, secure and fun community for seniors. ... to the community and live in their own homes. ...
(Date:9/15/2014)... MONDAY, Sept. 15, 2014 (HealthDay News) -- Births of ... complications and death than singleton births, researchers report. ... undergoing in vitro fertilization (IVF) could ease some of ... births have increased in tandem with births to older ... researchers from the University of New South Wales, Australia. ...
Breaking Medicine News(10 mins):Health News:New North Valley Surgery Center Is Arizona’s Largest Outpatient Facility 2Health News:New North Valley Surgery Center Is Arizona’s Largest Outpatient Facility 3Health News:New North Valley Surgery Center Is Arizona’s Largest Outpatient Facility 4Health News:C.R. Bard Transvaginal Mesh Lawsuits Move Forward, With Issuance of New Order in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports 2Health News:C.R. Bard Transvaginal Mesh Lawsuits Move Forward, With Issuance of New Order in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports 3Health News:Researcher develops and proves effectiveness of new drug for spinal muscular atrophy 2Health News:Avenidas Village Celebrates Anniversary 2Health News:Study Ties Multiple Births to Higher Costs, Complications 2Health News:Study Ties Multiple Births to Higher Costs, Complications 3
... ... increase exports, ... equity firm focused on investing across the African,continent, today announced ... leading personal care company and,producer of absorbent hygiene products. The ...
... Healthcare,Management Group, Inc. (Phyhealth) (Pink Sheets: PHYH), ... partnership with physicians,announced today that it has ... Group to manage the investments of Phyhealth ... Merrill Lynch will,manage the initial $2.5 million ...
... warm weather provides the,perfect opportunity to get fit ... plan that combines smarter eating habits with a ... "The key to controlling weight is to ... Fleming, Olympic figure skating,champion and HealthSaver spokesperson., ...
... /Xinhua-PRNewswire/ -- WuXi PharmaTech (NYSE:,WX), a leading ... outsourcing company with operations in China and ... the distinguished Stanford University,Professor Barry M. Trost ... PharmaTech and given two seminars on May ...
... May 20 Accelerate Brain Cancer,Cure ( http://www.abc2.org ... leading brain cancer specialists covering important updates on,advancements ... guidance for newly,diagnosed brain cancer patients., The ... of the worlds,leading researchers in the fields of ...
... that the frequency with which critically-ill patients developed ventilator-associated ... medical center such as Mayo Clinic compared to the ... Healthcare Safety Network (NHSN). This is good news for ... strong across the U.S. in intensive care units, which ...
Cached Medicine News:Health News:Emerging Capital Partners Invests $47.3 Million in North African Personal Care Company 2Health News:Phyhealth Enters Agreement with Merrill Lynch to Manage Capital Surplus Funds for Phyhealth Pilot HMO 2Health News:Figure Skater Peggy Fleming Teams With HealthSaver: Fit for Summer 2Health News:Figure Skater Peggy Fleming Teams With HealthSaver: Fit for Summer 3Health News:Figure Skater Peggy Fleming Teams With HealthSaver: Fit for Summer 4Health News:Figure Skater Peggy Fleming Teams With HealthSaver: Fit for Summer 5Health News:Stanford Professor Barry M. Trost Visits WuXi PharmaTech and Gives Two Seminars 2Health News:Brain Cancer Science and Treatment Information 2Health News:Intensive care units' prevention of pneumonia in critically-ill patients generally strong 2
Relocatable frame has been designed specifically for fractionated stereotactic radiotherapy treatments. It provides a fast, non-invasive and reproducible fixation of the patient....
The unique MR-frame and its indicators are made of a highly tensile and fibre reenforced Epoxyd material....
VG2 PLIF (Parallel) Posterior lumbar interbody fusion. Frozen preservation. Consists of two outer cortical planks, center cancellous plank, all from the same donor, held together by two press-fit cor...
An all-cortical structure provides the structural benefits of cortical bone. Precision machined to exact specifications to promote healthy lordosis and vertebral body distraction....
Medicine Products: